Human interleukin-2 biosimilar (Amoytop Biotech/BioGeneric Pharma)
人白细胞介素-2生物类似药 (Amoytop Biotech/BioGeneric Pharma)
Report date: 2022/01/14 13:23:58
Base Information
Drug NameHuman interleukin-2 biosimilar (Amoytop Biotech/BioGeneric Pharma)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaClinical
Originator CompaniesXiamen Amoytop Biotech Co LtdBiogeneric Pharma
China Registration ClassN/A
Develop Information
Active CompaniesBiogeneric PharmaXiamen Amoytop Biotech Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC Code
Related LinksN/A